Evaluation of serum thiol/disulfide homeostasis in patients with ankylosing spondylitis by a novel method.
暂无分享,去创建一个
O. Erel | Erkan Cüre | A. Omma | A. Kucuk | M. Cure | E. Doğan | R. Baykara | A. Tuzcu | G. Acet | A. Aydin
[1] O. Erel,et al. Thiol/disulfide homeostasis in patients with ankylosing spondylitis. , 2016, Bosnian journal of basic medical sciences.
[2] O. Erel,et al. Evaluation of thiol levels, thiol/disulfide homeostasis and their relation with inflammation in cardiac syndrome X , 2016, Coronary artery disease.
[3] O. Erel,et al. Thiol/disulphide homeostasis in pregnant women with Familial Mediterranean fever , 2016, Redox report : communications in free radical research.
[4] M. Nazıroğlu,et al. Anti-tumor Necrosis Factor Alpha (Infliximab) Attenuates Apoptosis, Oxidative Stress, and Calcium Ion Entry Through Modulation of Cation Channels in Neutrophils of Patients with Ankylosing Spondylitis , 2016, The Journal of Membrane Biology.
[5] O. Erel,et al. Dynamic thiol/disulphide homeostasis in patients with newly diagnosed primary hypertension. , 2016, Journal of the American Society of Hypertension : JASH.
[6] Ö. Erel,et al. The dynamic thiol/disulphide homeostasis in inflammatory bowel disease and its relation with disease activity and pathogenesis , 2016, International Journal of Colorectal Disease.
[7] O. Erel,et al. A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. , 2015, The American journal of emergency medicine.
[8] Ö. Erel,et al. The relation between oxidative stress parameters, ischemic stroke, and hemorrhagic stroke. , 2015, Turkish journal of medical sciences.
[9] S. Neşelioğlu,et al. Oxidative stress and decreased thiol level in patients with migraine: cross-sectional study , 2015, Acta Neurologica Belgica.
[10] S. Guler,et al. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation , 2015, Endocrine.
[11] O. Erel,et al. A novel and automated assay for thiol/disulphide homeostasis. , 2014, Clinical biochemistry.
[12] A. Zimmermann,et al. Subclinical atherosclerosis in ankylosing spondylitis: is there a role for inflammation? , 2013, Revista brasileira de reumatologia.
[13] M. Elarman,et al. Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis , 2013, Rheumatology International.
[14] A. Sieroń,et al. Decrease in antioxidant status of plasma and erythrocytes from patients with ankylosing spondylitis. , 2010, Clinical biochemistry.
[15] S. Akar,et al. Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor , 2010, Modern rheumatology.
[16] V. Venditti,et al. Protein–thiol substitution or protein dethiolation by thiol/disulfide exchange reactions: The albumin model , 2007, Proteins.
[17] T. Hurd,et al. Detection of Reactive Oxygen Species-sensitive Thiol Proteins by Redox Difference Gel Electrophoresis , 2007, Journal of Biological Chemistry.
[18] P. Montilla,et al. The effect of infliximab on oxidative stress in chronic inflammatory joint disease* , 2007, Current medical research and opinion.
[19] O. Altındag,et al. Serum oxidative–antioxidative status in patients with ankylosing spondilitis , 2007, Rheumatology International.
[20] Tae-Hwan Kim,et al. Pathogenesis of ankylosing spondylitis and reactive arthritis , 1994, Current opinion in rheumatology.
[21] M. Çalış,et al. Protein oxidation status in patients with ankylosing spondylitis. , 2004, Rheumatology.
[22] B. Sancak,et al. Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. , 2004, The Tohoku journal of experimental medicine.
[23] E. Märker-Hermann,et al. [Pathogenesis of ankylosing spondylitis-mechanisms of disease manifestation and chronicity]. , 2004, Zeitschrift fur Rheumatologie.
[24] S. Ozgoçmen,et al. Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis , 2004, Rheumatology International.
[25] A. Boonen,et al. Ankylosing spondylitis: an overview , 2002, Annals of the rheumatic diseases.
[26] E. Hickey,et al. Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death. , 2001, Free radical biology & medicine.
[27] F. Shabani,et al. The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCI) is suppressed by anti-rheumatic drugs. , 1998, Free radical research.
[28] A. Naganuma,et al. Determination of gamma-glutamylglutathione and other low-molecular-mass biological thiol compounds by isocratic high-performance liquid chromatography with fluorimetric detection. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[29] A. Calin,et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. , 1994, The Journal of rheumatology.
[30] A. Calin,et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. , 1994, The Journal of rheumatology.
[31] C. Cross,et al. Antioxidant protection against hypochlorous acid in human plasma. , 1993, The Journal of laboratory and clinical medicine.
[32] D. H. Brown,et al. Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. , 1987, British journal of rheumatology.
[33] M. Sadowska-Wroblewska. [Seronegative spondyloarthritis]. , 1983, Reumatologia.